Loading...
Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit
BACKGROUND: Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this signalling pathway is regulated is required. It has...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2324083/ https://ncbi.nlm.nih.gov/pubmed/18380891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2121-9-16 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|